[1]. Robot-assisted radical nephrectomy and inferior vena cava tumor thrombectomy using the novel surgical robot platform, hinotori: Initial experience with two cases.
IJU case reports [巻]7 [号]2 [頁]96 -99 （2024年） [査読] 有
[DOI] [2]. Relationship Between Adverse Events and Progression-free Survival in Patients Receiving Cabozantinib for Previously Treated Metastatic Renal Cell Carcinoma.
Anticancer research [巻]44 [号]2 [頁]781 -786 （2024年） [査読] 有
[DOI] [3]. Robot-assisted radical nephroureterectomy for upper urinary tract tumor: initial experience with the use of novel surgical robot system, hinotori.
Translational cancer research [巻]12 [号]12 [頁]3522 -3529 （2023年） [査読] 有
[DOI] [4]. Robot-assisted radical nephrectomy using novel surgical robot platform, hinotori: Report of initial series of 13 cases.
International journal of urology : official journal of the Japanese Urological Association [巻]30 [号]12 [頁]1175 -1179 （2023年） [査読] 有
[DOI] [5]. The Geriatric Nutritional Risk Index Predicts Prognosis in Japanese Patients with LATITUDE High-Risk Metastatic Hormone-Sensitive Prostate Cancer: A Multi-Center Study.
Cancers [巻]15 [号]22 [頁]5333 （2023年） [査読] 有
[DOI] [6]. Perioperative outcomes of robot-assisted partial nephrectomy using hinotori versus da Vinci surgical robot system: a propensity score-matched analysis.
Journal of robotic surgery [巻]17 [号]5 [頁]2435 -2440 （2023年） [査読] 有
[DOI] [7]. Assessments of therapeutic effects according to timings for combined therapy with axitinib and immune check point inhibitor in a mouse renal cell carcinoma model.
Scientific reports [巻]13 [号]1 [頁]11361 （2023年） [査読] 有
[DOI] [8]. Robot-assisted adrenalectomy using a hinotori surgical robot system: Report of first series of six cases.
Asian journal of endoscopic surgery [巻]16 [号]3 [頁]489 -495 （2023年） [査読] 有
[DOI] [9]. Trends in the Use of Second-Generation Androgen Receptor Axis Inhibitors for Metastatic Hormone-Sensitive Prostate Cancer and Clinical Factors Predicting Biological Recurrence
DIAGNOSTICS [巻]13 [号]9 [頁]1661 （2023年） [査読] 有
[DOI] [10]. Initial Experience of Robot-Assisted Partial Nephrectomy Using Hinotori Surgical Robot System: Single Institutional Prospective Assessment of Perioperative Outcomes in 30 Cases.
Journal of endourology （2023年） [査読] 有
[DOI] [11]. Predictive factors of de novo overactive bladder in clinically localized prostate cancer patients after robot-assisted radical prostatectomy.
International journal of urology : official journal of the Japanese Urological Association [巻]30 [号]1 [頁]57 -61 （2023年） [査読] 有
[DOI] [12]. Significance of second progression-free survival in patients with advanced urothelial cancer who received platinum-based combination chemotherapy followed by pembrolizumab.
International journal of urology : official journal of the Japanese Urological Association （2022年） [査読] 有
[DOI] [13]. ロボット支援下前立腺全摘除術(RARP)施行前後における勃起機能がQOLに与える影響について
日本性機能学会雑誌 (一社)日本性機能学会 [巻]37 [号]3 [頁]187 -188 （2022年） [査読] 無
[14]. Effects of Changes in Erectile Function After Holmium Laser Enucleation of the Prostate on Postoperative Outcomes in Patients With Benign Prostatic Hyperplasia.
In vivo (Athens, Greece) [巻]36 [号]6 [頁]2960 -2964 （2022年） [査読] 有
[DOI] [15]. Limited impact of erectile function on health-related quality of life in Japanese men undergoing robot-assisted radical prostatectomy.
International journal of urology : official journal of the Japanese Urological Association [巻]29 [号]9 [頁]956 -961 （2022年） [査読] 有
[DOI] [16]. Significant impact of a history of prior or concomitant upper urinary tract cancer on the recurrence and progression of non-muscle invasive bladder cancer.
Japanese journal of clinical oncology [巻]52 [号]8 [頁]944 -949 （2022年） [査読] 有
[DOI] [17]. Prognostic assessments in patients with upper tract urothelial carcinoma undergoing radical nephroureterectomy and systematic regional lymph node dissection.
Urologia [巻]89 [号]3 [頁]354 -357 （2022年） [査読] 有
[DOI] [18]. Feasibility of interaortocaval clamping for renal artery during robot-assisted right partial nephrectomy: A propensity score-matching analysis.
Asian journal of endoscopic surgery [巻]15 [号]3 [頁]531 -538 （2022年） [査読] 有
[DOI] [19]. Effects of Changes in Erectile Function After Holmium Laser Enucleation of the Prostate on Postoperative Outcomes in Patients With Benign Prostatic Hyperplasia.
In vivo (Athens, Greece) [巻]36 [号]6 [頁]2960 -2964 （2022年）
[DOI] [20]. Initial experience of robot-assisted radical nephrectomy in Japan: Single institutional study of 12 cases.
Asian journal of endoscopic surgery [巻]15 [号]1 [頁]162 -167 （2022年）
[DOI] [21]. Impact of Bladder Neck Angle Measured by Postoperative Magnetic Resonance Imaging on Midterm Recovery of Urinary Continence in Prostate Cancer Patients Undergoing Robot-Assisted Radical Prostatectomy.
Journal of endourology [巻]35 [号]11 [頁]1610 -1615 （2021年）
[DOI] [22]. Prognostic significance of third-line treatment for patients with metastatic castration-resistant prostate cancer: comparative assessments between cabazitaxel and other agents.
International journal of clinical oncology [巻]26 [号]9 [頁]1745 -1751 （2021年）
[DOI] [23]. Molecular Mechanism Mediating Cytotoxic Activity of Cabazitaxel in Docetaxel-resistant Human Prostate Cancer Cells.
Anticancer research [巻]41 [号]8 [頁]3753 -3758 （2021年）
[DOI] [24]. Perioperative outcomes in patients undergoing robot-assisted partial nephrectomy: Comparative assessments between complex and non-complex renal tumors.
Asian journal of endoscopic surgery [巻]14 [号]3 [頁]379 -385 （2021年）
[DOI] [25]. Significance of 5-Aminolevulinic Acid-mediated Photodynamic Diagnosis Following Standard Transurethral Resection in Non-muscle Invasive Bladder Cancer.
Cancer diagnosis & prognosis [巻]1 [号]3 [頁]201 -205 （2021年）
[DOI] [26]. Second transurethral resection for high-risk non-muscle invasive bladder cancer patients: a propensity score matched analysis.
Japanese journal of clinical oncology [巻]50 [号]6 [頁]718 -721 （2020年）
[DOI] [27]. Corticosteroids alleviate adverse events associated with enzalutamide in patients with metastatic castration-resistant prostate cancer.
Molecular and clinical oncology [巻]12 [号]5 [頁]495 -500 （2020年）
[DOI] [28]. Predictive factors for persistence of preoperative overactive bladder symptoms after transvaginal mesh surgery in women with pelvic organ prolapse.
Lower urinary tract symptoms [巻]12 [号]2 [頁]167 -172 （2020年）
[DOI] [29]. Assessment of Factors Predicting Disease Progression in Japanese Patients With Non-Metastatic Castration-resistant Prostate Cancer.
Anticancer research [巻]40 [号]2 [頁]1101 -1106 （2020年）
[DOI] [30]. Improved perioperative outcomes by early unclamping prior to renorrhaphy compared with conventional clamping during robot-assisted partial nephrectomy: a propensity score matching analysis.
Journal of robotic surgery [巻]14 [号]1 [頁]47 -53 （2020年）
[DOI] [31]. Enhanced Sensitivity to NVP-BEZ235 by Inhibition of p62/SQSTM1 in Human Bladder Cancer KoTCC-1 Cells Both and .
In vivo (Athens, Greece) [巻]34 [号]3 [頁]1001 -1008 （2020年）
[DOI] [32]. Robot-Assisted Partial Nephrectomy for Patients with Multifocal Renal Tumors Arising in a Solitary Kidney: Report of Three Cases.
Journal of endourology case reports [巻]6 [号]4 [頁]370 -373 （2020年）
[DOI] [33]. Feasibility of the ACL (albumin, C-reactive protein and lactate dehydrogenase) model as a novel prognostic tool in patients with metastatic renal cell carcinoma previously receiving first-line targeted therapy.
Urologic oncology [巻]38 [号]1 [頁]6.e9 -6.e16 （2020年）
[DOI] [34]. Initial learning curve for robot-assisted partial nephrectomy performed by a single experienced robotic surgeon.
Asian journal of endoscopic surgery [巻]13 [号]1 [頁]59 -64 （2020年）
[DOI] [35]. Significant impact of three-dimensional volumetry of perinephric fat on the console time during robot-assisted partial nephrectomy.
BMC urology [巻]19 [号]1 [頁]132 （2019年）
[DOI] [36]. Therapeutic Endoscopic Treatment Plus Maintenance Dimethyl Sulfoxide Therapy Prolongs Recurrence-Free Time in Patients With Hunner Type Interstitial Cystitis: A Pilot Study.
International neurourology journal [巻]23 [号]4 [頁]327 -333 （2019年）
[DOI] [37]. Comparative assessment of prognostic outcomes between first-generation antiandrogens and novel androgen-receptor-axis-targeted agents in patients with non-metastatic castration-resistant prostate cancer.
International journal of clinical oncology [巻]24 [号]7 [頁]842 -847 （2019年）
[DOI] [38]. Prognostic Significance of Time to Castration Resistance in Patients With Metastatic Castration-sensitive Prostate Cancer.
Anticancer research [巻]39 [号]3 [頁]1391 -1396 （2019年）
[DOI] [39]. Clinical Outcomes of 42 Renal Cell Carcinoma Patients With Metastases Solely to the Lung Who Received Sorafenib as Second-line Systemic Therapy.
Anticancer research [巻]39 [号]2 [頁]1067 -1072 （2019年）
[DOI] [40]. Significance of introduction of alternative dosing schedule for sunitinib during first-line treatment of patients with metastatic renal cell carcinoma.
Medical oncology (Northwood, London, England) [巻]35 [号]10 [頁]133 （2018年）
[DOI] [41]. Significance of De Ritis (Aspartate Transaminase/Alanine Transaminase) Ratio as a Significant Prognostic But Not Predictive Biomarker in Japanese Patients with Metastatic Castration-resistant Prostate Cancer Treated with Cabazitaxel.
Anticancer research [巻]38 [号]7 [頁]4179 -4185 （2018年）
[DOI] [42]. Effects of 25- and 30-degree Trendelenburg positions on intraocular pressure changes during robot-assisted radical prostatectomy.
Prostate international [巻]5 [号]4 [頁]135 -138 （2017年）
[DOI] [43]. Impact of metabolic syndrome on early recovery of continence after robot-assisted radical prostatectomy.
International journal of urology : official journal of the Japanese Urological Association [巻]24 [号]9 [頁]692 -697 （2017年）
[DOI] [44]. Safety and feasibility of robot-assisted radical prostatectomy for clinically localized prostate cancer in elderly Japanese patients.
Prostate international [巻]5 [号]1 [頁]13 -16 （2017年）
[DOI]